Hypertension in Canada: Past, Present, and Future

Canada has an extremely successful hypertension detection and treatment program. The aim of this review was to highlight the historic and current infrastructure and initiatives that have led to this success, and the outlook moving forward into the future. We discuss the evolution of hypertension awa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ernesto L. Schiffrin, Norman R.C. Campbell, Ross D. Feldman, Janusz Kaczorowski, Richard Lewanczuk, Raj Padwal, Sheldon W. Tobe
Formato: article
Lenguaje:EN
Publicado: Ubiquity Press 2016
Materias:
Acceso en línea:https://doaj.org/article/a0bb9ef01a03477192cc6137ecae9a4f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a0bb9ef01a03477192cc6137ecae9a4f
record_format dspace
spelling oai:doaj.org-article:a0bb9ef01a03477192cc6137ecae9a4f2021-12-02T06:31:53ZHypertension in Canada: Past, Present, and Future2214-999610.1016/j.aogh.2016.02.006https://doaj.org/article/a0bb9ef01a03477192cc6137ecae9a4f2016-06-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/746https://doaj.org/toc/2214-9996Canada has an extremely successful hypertension detection and treatment program. The aim of this review was to highlight the historic and current infrastructure and initiatives that have led to this success, and the outlook moving forward into the future. We discuss the evolution of hypertension awareness and control in Canada; contributions made by organizations such as the Canadian Hypertension Society, Blood Pressure Canada, and the Canadian Hypertension Education Program; the amalgamation of these organizations into Hypertension Canada; and the impact that Hypertension Canada has had on hypertension care in Canada. The important contribution that public policy and advocacy can have on prevention and control of blood pressure in Canada is described. We also highlight the importance of population-based strategies, health care access and organization, and accurate blood pressure measurement (including ambulatory, home, and automated office modalities) in optimizing hypertension prevention and management. We end by discussing how Hypertension Canada will move forward in the near and longer term to address the unmet residual risk attributable to hypertension and associated cardiovascular risk factors. Hypertension Canada will continue to strive to enhance hypertension prevention and control rates, thereby improving the quality of life and cardiovascular outcomes of Canadians, while at the same time creating a hypertension care model that can be emulated across the world.Ernesto L. SchiffrinNorman R.C. CampbellRoss D. FeldmanJanusz KaczorowskiRichard LewanczukRaj PadwalSheldon W. TobeUbiquity PressarticleInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 82, Iss 2, Pp 288-299 (2016)
institution DOAJ
collection DOAJ
language EN
topic Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
spellingShingle Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
Ernesto L. Schiffrin
Norman R.C. Campbell
Ross D. Feldman
Janusz Kaczorowski
Richard Lewanczuk
Raj Padwal
Sheldon W. Tobe
Hypertension in Canada: Past, Present, and Future
description Canada has an extremely successful hypertension detection and treatment program. The aim of this review was to highlight the historic and current infrastructure and initiatives that have led to this success, and the outlook moving forward into the future. We discuss the evolution of hypertension awareness and control in Canada; contributions made by organizations such as the Canadian Hypertension Society, Blood Pressure Canada, and the Canadian Hypertension Education Program; the amalgamation of these organizations into Hypertension Canada; and the impact that Hypertension Canada has had on hypertension care in Canada. The important contribution that public policy and advocacy can have on prevention and control of blood pressure in Canada is described. We also highlight the importance of population-based strategies, health care access and organization, and accurate blood pressure measurement (including ambulatory, home, and automated office modalities) in optimizing hypertension prevention and management. We end by discussing how Hypertension Canada will move forward in the near and longer term to address the unmet residual risk attributable to hypertension and associated cardiovascular risk factors. Hypertension Canada will continue to strive to enhance hypertension prevention and control rates, thereby improving the quality of life and cardiovascular outcomes of Canadians, while at the same time creating a hypertension care model that can be emulated across the world.
format article
author Ernesto L. Schiffrin
Norman R.C. Campbell
Ross D. Feldman
Janusz Kaczorowski
Richard Lewanczuk
Raj Padwal
Sheldon W. Tobe
author_facet Ernesto L. Schiffrin
Norman R.C. Campbell
Ross D. Feldman
Janusz Kaczorowski
Richard Lewanczuk
Raj Padwal
Sheldon W. Tobe
author_sort Ernesto L. Schiffrin
title Hypertension in Canada: Past, Present, and Future
title_short Hypertension in Canada: Past, Present, and Future
title_full Hypertension in Canada: Past, Present, and Future
title_fullStr Hypertension in Canada: Past, Present, and Future
title_full_unstemmed Hypertension in Canada: Past, Present, and Future
title_sort hypertension in canada: past, present, and future
publisher Ubiquity Press
publishDate 2016
url https://doaj.org/article/a0bb9ef01a03477192cc6137ecae9a4f
work_keys_str_mv AT ernestolschiffrin hypertensionincanadapastpresentandfuture
AT normanrccampbell hypertensionincanadapastpresentandfuture
AT rossdfeldman hypertensionincanadapastpresentandfuture
AT januszkaczorowski hypertensionincanadapastpresentandfuture
AT richardlewanczuk hypertensionincanadapastpresentandfuture
AT rajpadwal hypertensionincanadapastpresentandfuture
AT sheldonwtobe hypertensionincanadapastpresentandfuture
_version_ 1718399892331692032